MAIA Biotechnology (MAIA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.10, -1.79% vs the prior close of $1.12.
- Volume 362.85K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MAIA dips 1.8% to $1.10, a 6-month low, 5 down days in a row. Closed at $1.10, -1.79% vs the prior close of $1.12. Day range $1.08–$1.15, opened at $1.13.
MAIA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MAIA dips 1.8% to $1.10, a 6-month low, 5 down days in a row
- Closed at $1.10, -1.79% vs the prior close of $1.12. Day range $1.08–$1.15, opened at $1.13.
- Volume was 362.85K shares, 0.7x its 50-day average of 504.34K.
- Price is -15.1% vs its 50-day average ($1.30) and -25.8% vs its 200-day average ($1.48).
- 52-week range $0.87–$3.19; today's close sits at 10% of that range, 65.5% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — MAIA ends flat (+0.0%) to $1.12, 4 down days in a row
- Closed at $1.12, +0.00% vs the prior close of $1.12. Day range $1.10–$1.15, opened at $1.10.
- Volume was 295.40K shares, 0.6x its 50-day average of 503.95K — lighter than usual.
- Price is -14.0% vs its 50-day average ($1.30) and -24.5% vs its 200-day average ($1.48).
- 52-week range $0.87–$3.19; today's close sits at 11% of that range, 64.9% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — MAIA slides 3.4% to $1.12, a 6-month low, 3 down days in a row
- Closed at $1.12, -3.45% vs the prior close of $1.16. Day range $1.10–$1.16, opened at $1.15.
- Volume was 628.70K shares, 1.3x its 50-day average of 499.06K.
- Price is -14.3% vs its 50-day average ($1.31) and -24.6% vs its 200-day average ($1.48).
- 52-week range $0.87–$3.19; today's close sits at 11% of that range, 64.9% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — MAIA dips 1.7% to $1.16
- Closed at $1.16, -1.69% vs the prior close of $1.18. Day range $1.15–$1.18, opened at $1.18.
- Volume was 277.50K shares, 0.5x its 50-day average of 506.51K — lighter than usual.
- Price is -11.6% vs its 50-day average ($1.31) and -22.0% vs its 200-day average ($1.49).
- 52-week range $0.87–$3.19; today's close sits at 12% of that range, 63.6% below the 52-week high.
Oct 12, 2026 — MAIA slides 3.3% to $1.18
- Closed at $1.18, -3.28% vs the prior close of $1.22. Day range $1.16–$1.22, opened at $1.22.
- Volume was 229.90K shares, 0.5x its 50-day average of 506.55K — lighter than usual.
- Price is -10.3% vs its 50-day average ($1.32) and -20.7% vs its 200-day average ($1.49).
- 52-week range $0.87–$3.19; today's close sits at 13% of that range, 63.0% below the 52-week high.
Oct 9, 2026 — MAIA jumps 6.1% to $1.22
- Closed at $1.22, +6.09% vs the prior close of $1.15. Day range $1.16–$1.24, opened at $1.16.
- Volume was 374.60K shares, 0.7x its 50-day average of 504.87K.
- Price is -7.4% vs its 50-day average ($1.32) and -18.1% vs its 200-day average ($1.49).
- 52-week range $0.87–$3.19; today's close sits at 15% of that range, 61.8% below the 52-week high.
Oct 8, 2026 — MAIA dips 2.5% to $1.15
- Closed at $1.15, -2.54% vs the prior close of $1.18. Day range $1.13–$1.16, opened at $1.15.
- Volume was 677.10K shares, 1.4x its 50-day average of 501.42K.
- Price is -12.7% vs its 50-day average ($1.32) and -22.8% vs its 200-day average ($1.49).
- 52-week range $0.87–$3.19; today's close sits at 12% of that range, 63.9% below the 52-week high.
Oct 7, 2026 — MAIA dips 0.8% to $1.18
- Closed at $1.18, -0.84% vs the prior close of $1.19. Day range $1.16–$1.22, opened at $1.17.
- Volume was 359.50K shares, 0.7x its 50-day average of 504.64K.
- Price is -10.5% vs its 50-day average ($1.32) and -20.8% vs its 200-day average ($1.49).
- 52-week range $0.87–$3.19; today's close sits at 13% of that range, 63.0% below the 52-week high.
Oct 6, 2026 — MAIA rises 0.8% to $1.19
- Closed at $1.19, +0.85% vs the prior close of $1.18. Day range $1.17–$1.21, opened at $1.20.
- Volume was 227.20K shares, 0.4x its 50-day average of 507.28K — lighter than usual.
- Price is -9.8% vs its 50-day average ($1.32) and -20.2% vs its 200-day average ($1.49).
- 52-week range $0.87–$3.19; today's close sits at 14% of that range, 62.7% below the 52-week high.
- SEC filings that day: 8-K.
Oct 5, 2026 — MAIA dips 0.8% to $1.18
- Closed at $1.18, -0.84% vs the prior close of $1.19. Day range $1.17–$1.21, opened at $1.17.
- Volume was 531.00K shares, 1.1x its 50-day average of 504.76K.
- Price is -10.7% vs its 50-day average ($1.32) and -20.8% vs its 200-day average ($1.49).
- 52-week range $0.87–$3.19; today's close sits at 13% of that range, 63.0% below the 52-week high.
Oct 2, 2026 — MAIA rises 1.7% to $1.19
- Closed at $1.19, +1.71% vs the prior close of $1.17. Day range $1.17–$1.21, opened at $1.19.
- Volume was 405.00K shares, 0.8x its 50-day average of 505.59K.
- Price is -10.0% vs its 50-day average ($1.32) and -20.2% vs its 200-day average ($1.49).
- 52-week range $0.87–$3.19; today's close sits at 14% of that range, 62.7% below the 52-week high.
MAIA latest news & SEC filings
Every SEC filing by or about MAIA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 25, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 28, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 21, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$7.94M (prior year -$5.35M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.13 (prior year -$0.18) (loss narrowed vs Jun 30, 2025)
Things to know before you trade MAIA
- Last results release: Nov 7, 2023 (8-K Item 2.02). Previous ones: Aug 8, 2023, May 8, 2023, Mar 24, 2023. Based on that rhythm, the next report is likely around Feb 6, 2024 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.41% (largest 6.1%).
- Liquidity: about 587.14K shares (≈$645.86K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.10 vs a range of $0.87–$3.19 (10% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Vlad Vitoc bought 73,000 shares on Sep 14, 2026.
- Latest filings: 8-K Oct 6, 2026; 10-Q Aug 10, 2026; 8-K May 22, 2026.
- Share count: 60.83M shares outstanding (Aug 10, 2026), +84.4% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Pharmaceutical Preparations.
MAIA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.13 | 1.15 | 1.08 | 1.10 | 362.85K |
| Oct 15, 2026 | 1.10 | 1.15 | 1.10 | 1.12 | 295.40K |
| Oct 14, 2026 | 1.15 | 1.16 | 1.10 | 1.12 | 628.70K |
| Oct 13, 2026 | 1.18 | 1.18 | 1.15 | 1.16 | 277.50K |
| Oct 12, 2026 | 1.22 | 1.22 | 1.16 | 1.18 | 229.90K |
| Oct 9, 2026 | 1.16 | 1.24 | 1.16 | 1.22 | 374.60K |
| Oct 8, 2026 | 1.15 | 1.16 | 1.13 | 1.15 | 677.10K |
| Oct 7, 2026 | 1.17 | 1.22 | 1.16 | 1.18 | 359.50K |
| Oct 6, 2026 | 1.20 | 1.21 | 1.17 | 1.19 | 227.20K |
| Oct 5, 2026 | 1.17 | 1.21 | 1.17 | 1.18 | 531.00K |
| Oct 2, 2026 | 1.19 | 1.21 | 1.17 | 1.19 | 405.00K |
| Oct 1, 2026 | 1.18 | 1.22 | 1.15 | 1.17 | 781.00K |
| Sep 30, 2026 | 1.17 | 1.19 | 1.15 | 1.18 | 690.50K |
| Sep 29, 2026 | 1.20 | 1.22 | 1.15 | 1.15 | 677.40K |
| Sep 28, 2026 | 1.23 | 1.26 | 1.18 | 1.18 | 1.01M |
| Sep 25, 2026 | 1.27 | 1.33 | 1.20 | 1.20 | 920.60K |
| Sep 24, 2026 | 1.31 | 1.33 | 1.25 | 1.25 | 594.10K |
| Sep 23, 2026 | 1.35 | 1.36 | 1.30 | 1.32 | 621.50K |
| Sep 22, 2026 | 1.33 | 1.37 | 1.31 | 1.37 | 939.40K |
| Sep 21, 2026 | 1.35 | 1.38 | 1.30 | 1.33 | 1.14M |
About MAIA Biotechnology
MAIA Biotechnology (MAIA) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CHICAGO, IL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1878313.
MAIA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Steven M Chaouki | Director | Jul 2, 2026 |
| Ramiro Guerrero | Director | Sep 14, 2026 |
| Ngar Yee Louie | Director | Jul 2, 2026 |
| Cristian Luput | Director | Jul 2, 2026 |
| Stan Smith | Director | Jul 2, 2026 |
| Jean-Manasse Theagene | Director | Jul 2, 2026 |
| Vlad Vitoc | Chief Executive Officer | Sep 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Sergei Gryaznov | Chief Scientific Officer | Jun 2, 2026 |
| Jeffrey C Himmelreich | Head of Finance | Jun 1, 2026 |
| Vlad Vitoc | Chief Executive Officer | Sep 15, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 14, 2026 | Vlad Vitoc | Buy | 73,000 | $1.37 |
| Sep 14, 2026 | Vlad Vitoc | Buy | 73,000 | $1.37 |
| Sep 14, 2026 | Vlad Vitoc | Buy | 73,000 | $1.37 |
| Sep 14, 2026 | Vlad Vitoc | Buy | 73,000 | $1.37 |
| Sep 10, 2026 | Ramiro Guerrero | Buy | 37,595 | $1.32 |
| Sep 10, 2026 | Ramiro Guerrero | Buy | 37,595 | $1.32 |
| Sep 10, 2026 | Ramiro Guerrero | Buy | 37,595 | $1.32 |
| Sep 10, 2026 | Ramiro Guerrero | Buy | 37,595 | $1.32 |
| Aug 28, 2026 | Ramiro Guerrero | Buy | 46,620 | $1.35 |
| Aug 28, 2026 | Ramiro Guerrero | Buy | 46,620 | $1.35 |
| Aug 28, 2026 | Ramiro Guerrero | Buy | 46,620 | $1.35 |
| Aug 28, 2026 | Ramiro Guerrero | Buy | 46,620 | $1.35 |
| Aug 27, 2026 | Ramiro Guerrero | Buy | 78,239 | $1.39 |
| Aug 27, 2026 | Ramiro Guerrero | Buy | 78,239 | $1.39 |
| Aug 27, 2026 | Ramiro Guerrero | Buy | 78,239 | $1.39 |
MAIA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-22.40M | -0.70 | $-18.84M |
| Dec 31, 2024 | $0 | $-23.25M | -1.05 | $-15.70M |
| Dec 31, 2023 | $0 | — | -1.49 | $-13.07M |
| Dec 31, 2022 | $0 | — | -1.75 | $-12.10M |
Latest balance sheet: total assets $28.24M, total liabilities $7.57M, cash $0 (as of Jun 30, 2026).
MAIA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
| Aug 8, 2023 | 8-K Item 2.02 (results) | — |
| May 8, 2023 | 8-K Item 2.02 (results) | — |
| Mar 24, 2023 | 8-K Item 2.02 (results) | — |
| Nov 9, 2022 | 8-K Item 2.02 (results) | — |
| Aug 22, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MAIA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.